The present invention provides therapeutic and prophylactic compositions for use in treating and preventing disorders involved epithelial cell apoptosis, such as gastrointestinal disorders ( e.g ., inflammatory bowel disease, Crohn's disease or ulcerative colitis) in a subject, such as a human patient.